<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562782</url>
  </required_header>
  <id_info>
    <org_study_id>1110011995</org_study_id>
    <nct_id>NCT01562782</nct_id>
  </id_info>
  <brief_title>Change of Fructose to Fat in South Asians</brief_title>
  <official_title>Fructose-induced Hepatic De Novo Lipogenesis in South Asians</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Rogosin Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Rogosin Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hepatic de novo lipogenesis (DNL) in
      response to the ingestion of a mixture of glucose and fructose is greater in South Asians
      compared to controls (Caucasians).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      South Asians, who originate from the Indian subcontinent and make up one-fifth of the world's
      population, are among the highest number who suffer from heart disease and diabetes. The
      results of many research studies suggest that genes play a role in developing heart disease
      and diabetes that is made worse by the diet in the United States. Fructose is a sugar widely
      used in the American diet, and when consumed, it is taken up by the liver and changed into
      fats through a process called de novo lipogenesis (DNL). The current study will compare this
      change into fats in the liver between South Asians and Caucasians. The participants will be
      screened on the initial visit, and on the second visit, the DNL response will be measured in
      the blood over four hours after drinking one sweetened beverage, containing half glucose,
      half fructose, similar to a soft drink. We expect that DNL in response to fructose intake is
      higher in South Asians when compared to Caucasians and may partially explain why South Asians
      have earlier heart disease and diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2012</start_date>
  <completion_date type="Actual">October 10, 2013</completion_date>
  <primary_completion_date type="Actual">October 10, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fold Change in Plasma Very Low Density Lipoprotein (VLDL) Triglyceride Palmitate</measure>
    <time_frame>4 hours</time_frame>
    <description>Fold change in plasma very low density lipoprotein (VLDL) triglyceride palmitate between South Asians and Caucasians from baseline to 4 hours after an oral challenge of fructose:glucose, 1:1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fold Changes in VLDL Triglycerides in South Asians and Caucasians</measure>
    <time_frame>4 hours</time_frame>
    <description>1) A comparison of the fold changes in very low density lipoprotein triglycerides (VLDL TG)in the 2 study groups between 0 and 4 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Glucose Levels in 2 Study Groups</measure>
    <time_frame>1 hour</time_frame>
    <description>A comparison of peak levels of glucose at one hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Insulin Levels in 2 Study Groups</measure>
    <time_frame>1 hour</time_frame>
    <description>A comparison of the mean peak insulin level at one hour in each group. Insulin is expected to increase after ingestion of glucose/fructose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Gastric Inhibitory Protein (GIP) Levels in the 2 Study Groups</measure>
    <time_frame>2 hours</time_frame>
    <description>A comparison of the mean peak gastric inhibitory protein (GIP) at 2 hours in each group. GIP is expected to increase after ingestion of glucose/fructose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlations Between Fold Change in VLDL TG Palmitate and Other Biomarkers of Carbohydrate and Fat Metabolism</measure>
    <time_frame>4 hours</time_frame>
    <description>Correlations between fold change in VLDL TG palmitate at 4 hours with other biomarkers of carbohydrate and fat metabolism in each study group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fold Changes in Triglycerides in 2 Study Groups</measure>
    <time_frame>4 hours</time_frame>
    <description>1) A comparison of the fold changes in total triglycerides (TG) in the 2 study groups between 0 and 4 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Lactate Levels in 2 Study Groups</measure>
    <time_frame>1 hour</time_frame>
    <description>A comparison of peak levels of lactate (at one hour). Lactate is expected to increase after ingestion of glucose/fructose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nadir Non-esterified Fatty Acids (NEFA) Levels in 2 Study Groups</measure>
    <time_frame>2 hours</time_frame>
    <description>A comparison of the nadir level of non-esterified fatty acids (NEFA at 2 hours). NEFA are expected to decrease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Glucose in 2 Study Groups</measure>
    <time_frame>1 hour</time_frame>
    <description>A comparison of peak levels of glucose at 1 hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Elevated Triglycerides</condition>
  <condition>Diabetes</condition>
  <condition>Cardiovascular Disease</condition>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>South Asians</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group have only South Asian heritage. The intervention is Fructose + Glucose Beverage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caucasians</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group have only Caucasian heritage. The intervention is Fructose + Glucose Beverage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fructose + Glucose Beverage</intervention_name>
    <description>Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.</description>
    <arm_group_label>Caucasians</arm_group_label>
    <arm_group_label>South Asians</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females, 18-35 years of age.

          -  South Asian or Caucasian descent through self-identification (South Asians are to have
             both biological parents with ancestry from India, Pakistan, Sri Lanka, Nepal and
             Bangladesh and no known non-South Asian ancestry in parents; Caucasians are to have
             both biological parents who self-identify as Caucasian and no known non-Caucasian
             ancestry in parents).

          -  Body mass index (BMI) 18.0-24.9 kg/m2 with no history of obesity.

          -  Fasting glucose &lt;100 mg/dL, 2h glucose oral glucose tolerance test (OGTT) &lt; 140 mg/dL.

          -  triglycerides (TG) &lt;200 mg/dL, HDL cholesterol (HDL-C) &gt;30 mg/dL, LDL cholesterol
             (LDL-C) &lt;160 mg/dL.

          -  Willing and able to stop fish oil, fiber supplement, other non-prescribed
             vitamins/supplements for 1 week prior to visit #2 until completion of study.

          -  Willing to not drink alcohol for 24-hours before visit #2.

          -  Willing and able to provide informed consent.

        Exclusion Criteria:

          -  History of diabetes or other endocrine disorder, hepatitis or other liver disorder,
             HIV, or autoimmune disease.

          -  Medication(s) known to affect lipids, including hormonal contraceptives.

          -  Recent acute illness

          -  Gastrointestinal disease resulting in significant gastrointestinal dysfunction or
             malabsorption.

          -  Cigarette smoking

          -  History of ethanol abuse (current intake &gt;2 drinks/day) or illicit drugs.

          -  History of severe psychiatric illness

          -  If female, pregnant or breastfeeding

          -  Participation in an investigational drug study within one month of screening.

          -  Unusual diet or extreme level of physical activity

          -  Have any other condition, which in the opinion of the investigator, should prohibit
             the participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Hudgins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rogosin Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Rogosin Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College Clinical and Translational Science Center (CTSC)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2012</study_first_posted>
  <results_first_submitted>December 18, 2018</results_first_submitted>
  <results_first_submitted_qc>June 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 19, 2019</results_first_posted>
  <last_update_submitted>June 14, 2019</last_update_submitted>
  <last_update_submitted_qc>June 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Elevated triglycerides</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Lipid Metabolic Disorders</keyword>
  <keyword>Body Weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Hypertriglyceridemia</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between 4/2012 and 10/2013 fifteen South Asians and 15 Caucasians were studied as outpatients at the Weill Cornell Medical College Clinical and Translational Science Center (CTSC).</recruitment_details>
      <pre_assignment_details>At the CTSC clinic, consented volunteers had their medical history reviewed and a physical exam performed. A fasting blood sample was obtained to screen for lipid and biochemical abnormalities, thyroid and liver disease, anemia, pregnancy and diabetes/glucose intolerance.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Caucasians</title>
          <description>Control group: The arm is an oral sugar challenge with blood sampling over 4 hours.
Fructose + Glucose Beverage: Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.</description>
        </group>
        <group group_id="P2">
          <title>South Asians</title>
          <description>South Asian group: The arm is an oral sugar challenge with blood sampling over 4 hours.
Fructose + Glucose Beverage: Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>screen failure</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Caucasian</title>
          <description>Control group: The arm is an oral sugar challenge with blood sampling over 4 hours.
Fructose + Glucose Beverage: Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.</description>
        </group>
        <group group_id="B2">
          <title>South Asians</title>
          <description>Experimental group: The arm is an oral sugar challenge with blood sampling over 4 hours.
Fructose + Glucose Beverage: Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" spread="3"/>
                    <measurement group_id="B2" value="26" spread="5"/>
                    <measurement group_id="B3" value="27" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fold Change in Plasma Very Low Density Lipoprotein (VLDL) Triglyceride Palmitate</title>
        <description>Fold change in plasma very low density lipoprotein (VLDL) triglyceride palmitate between South Asians and Caucasians from baseline to 4 hours after an oral challenge of fructose:glucose, 1:1.</description>
        <time_frame>4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Fold Change in Plasma Very Low Density Lipoprotein (VLDL) Triglyceride Palmitate</title>
          <description>Fold change in plasma very low density lipoprotein (VLDL) triglyceride palmitate between South Asians and Caucasians from baseline to 4 hours after an oral challenge of fructose:glucose, 1:1.</description>
          <units>fold change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" spread="0.87"/>
                    <measurement group_id="O2" value="1.85" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The equivalence test was used to compare the fold change in plasma VLDL triglyceride palmitate in Caucasians and South Asians.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups in the primary outcome- the mean fold change in plasma VLDL triglyceride palmitate, 0-4 hours. A power calculation was based on data obtained in 15 overweight subjects. Assuming a mean absolute difference of 2.7 in South Asians and 1.0 in Caucasians and a standard deviation of 2.0 for both, group sample sizes of 16 and 16 were expected to achieve 80% power to detect a difference of 1.7 using a 2-sided Mann-Whitney test.</non_inferiority_desc>
            <p_value>0.05</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.61</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fold Changes in VLDL Triglycerides in South Asians and Caucasians</title>
        <description>1) A comparison of the fold changes in very low density lipoprotein triglycerides (VLDL TG)in the 2 study groups between 0 and 4 hours.</description>
        <time_frame>4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Fold Changes in VLDL Triglycerides in South Asians and Caucasians</title>
          <description>1) A comparison of the fold changes in very low density lipoprotein triglycerides (VLDL TG)in the 2 study groups between 0 and 4 hours.</description>
          <units>fold change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.56"/>
                    <measurement group_id="O2" value="1.44" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The equivalence test was used to compare 1) the fold change in triglycerides in South Asians and Caucasians and 2) the fold change in VLDL triglycerides in South Asians and Caucasians.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Glucose Levels in 2 Study Groups</title>
        <description>A comparison of peak levels of glucose at one hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Glucose Levels in 2 Study Groups</title>
          <description>A comparison of peak levels of glucose at one hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.16" spread="1.83"/>
                    <measurement group_id="O2" value="5.61" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The equivalence test is used to compare levels after the sugar beverage of 1) glucose at 1 hour 2) lactate at 1 hour 3) NEFA at 2 hours in South Asians vs Caucasians.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Insulin Levels in 2 Study Groups</title>
        <description>A comparison of the mean peak insulin level at one hour in each group. Insulin is expected to increase after ingestion of glucose/fructose.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Insulin Levels in 2 Study Groups</title>
          <description>A comparison of the mean peak insulin level at one hour in each group. Insulin is expected to increase after ingestion of glucose/fructose.</description>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="78"/>
                    <measurement group_id="O2" value="111" spread="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Gastric Inhibitory Protein (GIP) Levels in the 2 Study Groups</title>
        <description>A comparison of the mean peak gastric inhibitory protein (GIP) at 2 hours in each group. GIP is expected to increase after ingestion of glucose/fructose.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Gastric Inhibitory Protein (GIP) Levels in the 2 Study Groups</title>
          <description>A comparison of the mean peak gastric inhibitory protein (GIP) at 2 hours in each group. GIP is expected to increase after ingestion of glucose/fructose.</description>
          <units>ng/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="277" spread="90"/>
                    <measurement group_id="O2" value="274" spread="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlations Between Fold Change in VLDL TG Palmitate and Other Biomarkers of Carbohydrate and Fat Metabolism</title>
        <description>Correlations between fold change in VLDL TG palmitate at 4 hours with other biomarkers of carbohydrate and fat metabolism in each study group.</description>
        <time_frame>4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Correlations Between Fold Change in VLDL TG Palmitate and Other Biomarkers of Carbohydrate and Fat Metabolism</title>
          <description>Correlations between fold change in VLDL TG palmitate at 4 hours with other biomarkers of carbohydrate and fat metabolism in each study group.</description>
          <units>r (correlation coefficient)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>fold change VLDL TG palmitate 4h: VLDL TG 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1137"/>
                    <measurement group_id="O2" value="0.0127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmita 4h:fold change VLDL TG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3339"/>
                    <measurement group_id="O2" value="0.3149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmitate 4h:total TG 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2320"/>
                    <measurement group_id="O2" value="0.0359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmitat: fold change total TG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3340"/>
                    <measurement group_id="O2" value="0.3290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmitate 4h:cholesterol 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0327"/>
                    <measurement group_id="O2" value="-0.3910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmitat 4h:HDL cholesterol 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0883"/>
                    <measurement group_id="O2" value="-0.3743"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmita 4h:apolipoprotein B 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0587"/>
                    <measurement group_id="O2" value="-0.1459"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palm 4h:LDL particle number 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0045"/>
                    <measurement group_id="O2" value="-0.0849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:LDL size 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1508"/>
                    <measurement group_id="O2" value="0.0359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VLDL TG palmitate 4h:glucose 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2444"/>
                    <measurement group_id="O2" value="0.0188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:glucose AUC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2677"/>
                    <measurement group_id="O2" value="-0.1569"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:insulin 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2778"/>
                    <measurement group_id="O2" value="-0.1151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:insulin AUC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1886"/>
                    <measurement group_id="O2" value="-0.0070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:NEFA 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0241"/>
                    <measurement group_id="O2" value="-0.5689"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:NEFA nadir 2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1319"/>
                    <measurement group_id="O2" value="-0.6151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:lactate 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1082"/>
                    <measurement group_id="O2" value="0.4382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:lactate peak 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1393"/>
                    <measurement group_id="O2" value="-0.1953"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:GIP 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3237"/>
                    <measurement group_id="O2" value="-0.2644"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:GIP peak 2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2889"/>
                    <measurement group_id="O2" value="-0.0453"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:HOMA-R 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2892"/>
                    <measurement group_id="O2" value="-0.1104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:HOMA-B% 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2347"/>
                    <measurement group_id="O2" value="0.2959"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fold change VDLD TG palmitate 4h:hsCRP 0h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0278"/>
                    <measurement group_id="O2" value="0.2463"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The equivalence test was used to analyze the relationship between the primary outcome, fold change in VLDL TG palmitate, and the listed levels of biomarkers of carbohydrate and fat metabolism. The correlation analysis was performed on data from each study group separately.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>Pearson or Spearman's rank test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fold Changes in Triglycerides in 2 Study Groups</title>
        <description>1) A comparison of the fold changes in total triglycerides (TG) in the 2 study groups between 0 and 4 hours.</description>
        <time_frame>4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Fold Changes in Triglycerides in 2 Study Groups</title>
          <description>1) A comparison of the fold changes in total triglycerides (TG) in the 2 study groups between 0 and 4 hours.</description>
          <units>fold change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.56"/>
                    <measurement group_id="O2" value="1.43" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Lactate Levels in 2 Study Groups</title>
        <description>A comparison of peak levels of lactate (at one hour). Lactate is expected to increase after ingestion of glucose/fructose.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Lactate Levels in 2 Study Groups</title>
          <description>A comparison of peak levels of lactate (at one hour). Lactate is expected to increase after ingestion of glucose/fructose.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="1.15"/>
                    <measurement group_id="O2" value="3.91" spread="0.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nadir Non-esterified Fatty Acids (NEFA) Levels in 2 Study Groups</title>
        <description>A comparison of the nadir level of non-esterified fatty acids (NEFA at 2 hours). NEFA are expected to decrease.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Nadir Non-esterified Fatty Acids (NEFA) Levels in 2 Study Groups</title>
          <description>A comparison of the nadir level of non-esterified fatty acids (NEFA at 2 hours). NEFA are expected to decrease.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.05"/>
                    <measurement group_id="O2" value="0.09" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Glucose in 2 Study Groups</title>
        <description>A comparison of peak levels of glucose at 1 hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caucasians</title>
            <description>Caucasian control group</description>
          </group>
          <group group_id="O2">
            <title>South Asians</title>
            <description>South Asian experimental group</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Glucose in 2 Study Groups</title>
          <description>A comparison of peak levels of glucose at 1 hour. Glucose is expected to increase after ingestion of glucose/fructose.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.16" spread="1.83"/>
                    <measurement group_id="O2" value="5.61" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>A P value &lt;0.05 was used to determine no equivalence between groups.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 hours per participant.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Caucasians</title>
          <description>Caucasian control group</description>
        </group>
        <group group_id="E2">
          <title>South Asians</title>
          <description>South Asian experimental group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <description>Mild nausea after ingestion of beverage in one subject.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lisa Hudgins, M.D.</name_or_title>
      <organization>The Rogosin Institute</organization>
      <phone>646-317-0805</phone>
      <email>lih2013@nyp.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

